Latest Type 1 hypersensitivity Stories
DALLAS, October 13, 2014 /PRNewswire/ -- The EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 is a 30 pages market research published in October
Aratana to Develop CRTH2 Antagonist for Atopic Dermatitis in Companion Animals KANSAS CITY, Kan. and OXFORD, United Kingdom, Oct.
ROUND ROCK, Texas, Oct.
-- Today is the first ever International Urticaria Day, an international event to increase urticaria awareness and improve care around the globe and let people living with urticaria
TARRYTOWN, N.Y. and PARIS, Sept. 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Margo Weaver, a Florida-based author, has released a new book aimed at helping children suffering from eczema to become more comfortable in their skin. APOPKA,
Video Will Aim to Address Gaps in Knowledge About Life-Threatening (Severe) Allergies PITTSBURGH, Aug.
OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment
An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis.
Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- totally perplexed and mixed up.